Serinus Biosciences
Combinations therapy by rational design
Serinus Biosciences is a company in healthcare based in New York, NY, USA.
Profile
Serinus Biosciences is tackling one of the toughest problems in cancer treatment: creating combination therapies to override treatment resistance. We leverage cutting edge technology to design a fully explainable AI platform primed with decades of system biology knowledge. Uniquely powered for biological inference, our AI engine uncovers how cancer cells evolve treatment resistance and identifies molecules to overcome resistance escape routes. We design combinations that are safer, more effective, and can get to patients quickly. Founded by MIT PhDs and supported by a scientific advisory board of top academics from the Broad Institute, Dana-Farber, and UCSD, Serinus is powered by Y Combinator and other top investors to revolutionize precision medicine.
Serinus Biosciences is positioned in healthcare, a segment that rewards a clear, focused offering.
The business is associated with New York, NY, USA.
The company is listed at the Summer 2022 stage of development.
Recorded headcount: 6 employees.
| Sector | Healthcare |
|---|---|
| Headquarters | New York, NY, USA |
| Country | USA |
| Employees | 6 |
| Stage | Summer 2022 |
Website: www.serinus.bio
Browse related
Create a free account